Thang V Pham Selected Research

Protein Kinase Inhibitors

1/2022	Phosphoproteomic profiling of T cell acute lymphoblastic leukemia reveals targetable kinases and combination treatment strategies.
2/2021	Time dependent effect of cold ischemia on the phosphoproteome and protein kinase activity in fresh-frozen colorectal cancer tissue obtained from patients.
2/2020	Kinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome.
10/2018	Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thang V Pham Research Topics

Disease

38	Neoplasms (Cancer) 02/2022 - 12/2007
11	Colorectal Neoplasms (Colorectal Cancer) 02/2021 - 05/2010
5	Adenoma (Adenomas) 01/2020 - 05/2010
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 01/2018
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 09/2009
3	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2016
3	Inflammation (Inflammations) 01/2022 - 07/2012
3	Carcinogenesis 01/2021 - 01/2010
3	Breast Neoplasms (Breast Cancer) 09/2016 - 07/2012
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 04/2016
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2021 - 01/2021
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 10/2013
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 06/2014
2	Dementia (Dementias) 01/2020 - 01/2016
2	Lung Neoplasms (Lung Cancer) 11/2019 - 01/2019
2	Carcinoma (Carcinomatosis) 05/2014 - 05/2010
1	Squamous Cell Carcinoma of Head and Neck 02/2022
1	Pulmonary Hypertension 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Atrial Fibrillation 01/2021
1	Left Ventricular Outflow Obstruction 01/2021
1	Cholangiocarcinoma 01/2020
1	Cognitive Dysfunction 01/2020
1	Adenocarcinoma 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2019
1	Chronic Renal Insufficiency 10/2019
1	Ciliopathies 10/2019
1	Testicular Neoplasms (Testicular Cancer) 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2017
1	Temporal Lobe Epilepsy 08/2016
1	Status Epilepticus (Complex Partial Status Epilepticus) 08/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2016

Drug/Important Bio-Agent (IBA)

29	Proteins (Proteins, Gene)FDA Link 02/2022 - 11/2009
27	Biomarkers (Surrogate Marker)IBA 02/2022 - 12/2007
13	ProteomeIBA 07/2021 - 05/2010
8	Phosphotransferases (Kinase)IBA 01/2022 - 10/2018
7	Pharmaceutical PreparationsIBA 01/2022 - 05/2013
6	Peptides (Polypeptides)IBA 02/2021 - 09/2009
4	Sunitinib (Sutent)FDA Link 01/2022 - 06/2016
4	Protein Kinase InhibitorsIBA 01/2022 - 10/2018
4	Tyrosine Kinase InhibitorsIBA 01/2022 - 09/2015
4	PhosphopeptidesIBA 01/2022 - 09/2015
3	Biological ProductsIBA 02/2021 - 01/2010
3	Cisplatin (Platino)FDA LinkGeneric 11/2019 - 05/2013
2	PhosphotyrosineIBA 01/2022 - 01/2017
2	RNA (Ribonucleic Acid)IBA 10/2021 - 10/2017
2	Tumor Biomarkers (Tumor Markers)IBA 07/2021 - 01/2010
2	Protein Kinases (Protein Kinase)IBA 02/2021 - 01/2019
2	Sorafenib (BAY 43-9006)FDA Link 02/2020 - 10/2018
2	Everolimus FDA Link 02/2020 - 10/2018
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2020 - 10/2018
2	Dasatinib (BMS 354825)FDA Link 02/2020 - 10/2018
2	Tyrosine (L-Tyrosine)FDA Link 02/2020 - 06/2016
2	AntigensIBA 01/2020 - 09/2014
2	Small Interfering RNA (siRNA)IBA 10/2017 - 06/2015
2	Kainic Acid (Kainate)IBA 08/2016 - 07/2015
2	EnzymesIBA 01/2016 - 10/2013
2	Membrane Proteins (Integral Membrane Proteins)IBA 09/2014 - 11/2009
2	ChromatinIBA 05/2014 - 05/2010
1	von Willebrand FactorIBA 01/2022
1	epidermal growth factor receptor VIIIIBA 10/2021
1	serum P-component (CIt)IBA 02/2021
1	CDX2 Transcription FactorIBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Interleukin-12 (IL 12)IBA 01/2021
1	ParaffinIBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	CytokinesIBA 01/2021
1	TubulinIBA 01/2021
1	amsonic acid (DAS)IBA 02/2020
1	VemurafenibIBA 02/2020
1	Blood Proteins (Serum Proteins)IBA 01/2020
1	HaptoglobinsIBA 01/2020
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2020
1	EphA2 ReceptorIBA 01/2020
1	BilirubinIBA 01/2020
1	CarbohydratesIBA 01/2020
1	bis(p-chlorophenyl)acetic acid (DDA)IBA 01/2020
1	Calcibiotic Root Canal SealerIBA 01/2020
1	iodoHis(3)- neurokinin A (INKA)IBA 12/2019
1	PlatinumIBA 01/2019
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2019
1	taxaneIBA 01/2019
1	Gemcitabine FDA Link 01/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019
1	Conditioned Culture MediaIBA 01/2019
1	Lapatinib (GW572016)FDA Link 10/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2018
1	Complement System Proteins (Complement)IBA 12/2017
1	Hemoglobins (Hemoglobin)IBA 12/2017
1	RNA Splicing FactorsIBA 10/2017
1	Cadherins (E-Cadherin)IBA 09/2016
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 09/2016

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 11/2019 - 09/2009
4	Therapeutics 07/2021 - 03/2014
1	Endarterectomy (Thromboendarterectomy) 01/2022
1	Precision Medicine 01/2017